8BKG44 · 6 credits · Basic level (G2X) · Medicinsk biologi
Pharmaceutical Development
Active · next start VT 2027
95%
passed the latest regular sitting
44WE · 3 Jun 2026 · 42 students
96%
passed the regular sittings, all sittings over the last 5 years
44WE · 190 students
8%
Harder than 8% of courses at basic level
Compared with 874 courses at the same level, ordinary exams over the last three academic years. 88 students.
Part of 1 programme
Other module
44WE Written examination
- 5
- 4
- 3
- U
Main rounds
96% passed · 190 students
- 95%42
- 100%46
- 98%42
- 86%29
- 97%31
Later rounds
88% passed · 17 students
- 80%5
- 80%5
- 100%7
- Pass a later round: 88% (17 students), compared with 96% (190 students) on the ordinary exam
- Get 4 or 5: 75% (207 students)
Show small sittings (5)
Sittings with fewer than 5 students, often credit transfers or special sittings. They are not part of any figure on this page.
- 100%3
- 50%2
- 0%1
- 100%1
- 100%1
Other modules
Partial exams, hand-ins and labs. They are not part of the figures at the top.
Other module
44CE Compulsory elements
- G
Main rounds
100% passed · 206 students
- 100%42
- 100%46
- 100%45
- 100%32
- 100%41
Later rounds
No sittings with at least 5 students.
Show small sittings (1)
Sittings with fewer than 5 students, often credit transfers or special sittings. They are not part of any figure on this page.
- 100%1
About the course
Aim
Knowledge and understanding
Having completed the course, the student is expected to be able to:
- Describe the principles of selection and validation of target molecules in drug development
- Describe how candidate molecules are identified and then developed into drugs
- Describe how drug candidates are evaluated with respect to potential toxicity in animal models
- Describe the principles of clinical trials and the regulatory process
- Describe the principles and methods of the production and quality monitoring of drugs
- Describe how protein drugs are produced
Skills and abilities
Having completed the course, the student is expected to be able to:
- Assess and communicate the results of preclinical and clinical drug trials
Judgement ability and approach
Having completed the course, the student is expected to be able to:
- Critically appraise and evaluate drug development from a medical, ethical and social perspective.
Content
The course is a basic theoretical course in drug development that is taught in parallel with Project Course: Pharmaceutical Development. The course aims to provide a general understanding of how small molecules and proteins are developed into drugs within areas such as cancer, cardiovascular diseases and inflammatory diseases. The course also aims to provide an understanding of clinical trials and the regulatory process, as well as the monitoring of side effects. A general overview of the production of drugs and pharmaceutical preparations is included.
The course encompasses the fields pharmaceutical development and pharmacology, with links to cell biology, physiology, pathology and biochemistry.
- Examiner
- Henrik Green
- Main field of study
- Medicinsk biologi